Announcements
- Enovis to Participate in Investor Conferences in June
- Enovis Announces First Quarter 2023 Results
- Enovis to Host First Quarter 2023 Results Conference Call on May 4th
- Enovis to Acquire Novastep
- ENOVIS™ Showcases Next Generation of Medical Technology at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
- Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023
- Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023
- Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
- Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
- Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 55.05 |
Average volume | 820.00 |
---|---|
Shares outstanding | 54.50m |
Free float | 48.01m |
P/E (TTM) | -- |
Market cap | 3.02bn USD |
EPS (TTM) | -0.4469 USD |
Data delayed at least 20 minutes, as of Jun 05 2023.
More ▼